Bacteria, antibiotics and COPD Source: Eur Respir J 2001; 17: 995-1007 Year: 2001
Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002
Antibiotic treatment and prevention of exacerbations of COPD Source: Eur Respir Monogr 2013; 60: 96-106 Year: 2013
Antibiotic treatment and prophylaxis Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006
Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 138s Year: 2001
The effect of 3 months oral clarithromycin on sputum bacterial colonization in stable moderate- to- severe chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001
Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease Source: International Congress 2018 – Pharmacological management of COPD Year: 2018
Why short-term antibiotic use in AECB may influence long-term outcomes Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016 Year: 2017
Prevention of exacerbations of COPD with pharmacotherapy Source: Eur Respir Rev 2009; 19: 119-126 Year: 2010
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval Source: Eur Respir J 2004; 24: 947-953 Year: 2004
Penetration of moxifloxacin in bronchial secretions in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
Severe exacerbations of chronic obstructive pulmonary disease (COPD) due to Pseudomonas aeruginosa : resistance to common antibiotics Source: Eur Respir J 2001; 18: Suppl. 33, 540s Year: 2001
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results Source: Eur Respir J 2012; 40: 17-27 Year: 2012
Use of antibiotics, antioxidants, mucolytics and vaccines in the therapy of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=296 Year: 2006
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002
Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Source: Eur Respir J 2002; 19: 966-975 Year: 2002
Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005
A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007